SFRS16 Activators
SFRS16 initiate a cascade of intracellular events that result in the functional activation of the protein. Forskolin, by elevating cAMP levels in cells, can enhance SFRS16 activity through the activation of protein kinase A (PKA). PKA then phosphorylates substrates that interact with or regulate SFRS16, thereby modulating its activity. Another cAMP elevator, Isoproterenol, operates through a similar mechanism, activating PKA and influencing SFRS16 activity. Ionomycin and A-23187, both calcium ionophores, raise intracellular calcium levels, which in turn can activate calmodulin-dependent kinase (CaMK). CaMK, once active, is capable of phosphorylating proteins that associate with SFRS16, leading to its activation. Phorbol 12-myristate 13-acetate (PMA) works through a different pathway, activating protein kinase C (PKC), which can phosphorylate proteins in the SFRS16 complex. This phosphorylation of regulatory proteins is a crucial step in SFRS16 activation.
Growth factors such as Epidermal Growth Factor (EGF) trigger their receptor tyrosine kinases, initiating a signaling cascade that can culminate in the activation of the MAPK/ERK pathway. The proteins phosphorylated by this pathway can influence the regulatory complex of SFRS16, leading to its activation. Similarly, Insulin stimulates the insulin receptor, leading to the activation of the PI3K/Akt pathway and subsequent phosphorylation of SFRS16-associated proteins. Anisomycin, a JNK activator, promotes the activation of the JNK pathway, which also phosphorylates proteins that are part of the SFRS16 activation process. Conversely, Okadaic Acid and Calyculin A inhibit protein phosphatases such as PP1 and PP2A, preventing dephosphorylation and thus maintaining proteins in a state that supports SFRS16 activity. Sphingosine-1-phosphate, through its receptors, can initiate signaling pathways that lead to the activation of SFRS16. Lastly, AICAR activates AMP-activated protein kinase (AMPK), which phosphorylates various downstream targets that can interact with and activate SFRS16, playing a role in the cellular energy response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Increased calcium can activate calmodulin-dependent kinase (CaMK), which may phosphorylate proteins associated with SFRS16, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). PKC may then phosphorylate regulatory proteins that are part of the SFRS16 functional complex, resulting in SFRS16 activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, triggering the PI3K/Akt pathway, which may lead to the phosphorylation of proteins that interact with SFRS16, enhancing its functional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can lead to the activation of the JNK pathway, resulting in the phosphorylation of proteins that can promote SFRS16 functional activation as part of stress response. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. This could result in enhanced phosphorylation of proteins in the SFRS16 complex, thereby promoting its functional activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A is also a potent inhibitor of protein phosphatases. By inhibiting dephosphorylation, it may indirectly maintain the phosphorylation state of proteins that activate SFRS16. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, similar to forskolin. This can activate PKA, potentially leading to the phosphorylation of proteins that regulate SFRS16 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A-23187 is another calcium ionophore like ionomycin, which can elevate intracellular calcium and activate downstream kinases such as CaMK, potentially resulting in the activation of SFRS16-associated proteins. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can trigger signaling pathways leading to the rearrangement of cytoskeletal elements and activation of proteins that associate with SFRS16. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK). Activated AMPK can phosphorylate downstream targets that may interact with and activate SFRS16 as part of the cellular energy response. | ||||||